Trial intelligence / Profile preview

Effect of Carvedilol and Diclofenac on CYP-mediated Drug Metabolism

NCT06566794Completed

Sponsor
Helsinki University Hospital
Start
Aug 2024
Primary completion
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial comparing Placebo, Carvedilol and Diclofenac (3 arms). Primary endpoint: Area under the plasma concentration - time curve at 23 hours. Started Aug 2024; status: completed.

02

Drugs

carvediloldiclofenac

Beyond the preview

Go deeper on NCT06566794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06566794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call